Cycurion, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

CYCU$2.47+3.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	June 30, 2026	December 31, 2025
Assets:
Cash and cash equivalents	$1,873,287	$5,255,235
Accounts receivable, net	3,721,520	2,687,479
Prepaid expenses and other current assets	222,886	60,133
Other receivables	133,058	-
Total current assets	5,950,751	8,002,847
Software development costs, net	4,798,981	4,606,981
Goodwill and intangibles	27,617,398	20,842,508
Total non-current assets	32,416,379	25,449,489
Total assets	$38,367,130	$33,452,336
Liabilities and Stockholders' Equity:
Liabilities:
Bank loan-revolving credit line	$2,421,305	$2,933,396
Loans payable - current portion	269,068	669,693
Factoring liability	1,300,470	1,511,678
Convertible notes	2,686,748	192,897
Promissory notes	1,161,960	2,499,662
Loans payable - related parties	123,650	123,650
Accounts payable	1,290,801	1,314,772
Accrued liabilities	7,613,943	4,228,337
Accrued compensation and benefits	1,063,856	919,825
Accrued interest payable	432,748	1,347,787
Excise tax payable	1,167,173	1,167,173
Total current liabilities	19,531,722	16,908,870
Loans payable - non-current portion	627,010	300,000
Total non-current liabilities	627,010	300,000
Total liabilities	20,158,732	17,208,870
Commitments and contingencies (Note 19)
Stockholders' Equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized)
Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively)	-	-
Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 1 issued and outstanding, respectively)	-	-
Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 2,547 and 4,851 issued and outstanding, respectively)	-	-
Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 150,000 issued and outstanding, respectively)	15	15
Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 51 issued and outstanding, respectively)	-	-
Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively)	-	-
Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 143 and 143 issued and outstanding, respectively)	-	-
Series H convertible preferred stock ($0.0001 par value, 10,000 shares designated, 1,900 and 0 issued and outstanding, respectively)	-	-
Series I convertible preferred stock ($0.0001 par value, 888,888 shares designated, 888,888 and 0 issued and outstanding, respectively)	89	-
Common stock ($0.0001 par value, 300,000,000 shares authorized, 11,889,767 and 3,642,501 shares issued and outstanding, respectively)	1,189	364
Additional paid in capital	55,545,133	46,979,762
Accumulated deficit	(32,763,317)	(26,879,081)
Total stockholders' equity attributable to Cycurion	22,783,109	20,101,060
Deficit attributable to noncontrolling interests	(4,574,711)	(3,857,594)
Total stockholders' equity	18,208,398	16,243,466
Total liabilities and stockholders’ equity	$38,367,130	$33,452,336
See accompanying notes to unaudited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.